• Home

Home > Medical Reference > Patient Education

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Life-Threatening Complications
• Diagnosis
• Dietary Goals and Exercise
• Treatment
• Monitoring Tests
• Long-Term Complications
• Transplantation Procedures
• Prevention
• Resources
• References

Diabetes - type 1

Description

An in-depth report on the causes, diagnosis, and treatment of type 1 diabetes.

Alternative Names

Type 1 diabetes; Insulin-dependent diabetes; Juvenile diabetes

Highlights

Drug Approvals

• Exubera, an inhaled form of insulin, was approved by the FDA in 2006. It is the first non-injected type of insulin. It is approved for adults with type 1 or type 2 diabetes.
• Pramlintide (Symlin), a new injectable drug, was approved in 2005. It is used in addition to insulin for adults who have trouble controlling their blood sugar. Pramlintide and insulin are the only two approved treatments for type 1 diabetes.

Investigational Drugs

A CD3 antibody drug may help stimulate insulin production in patients with type 1 diabetes and reduce their need for supplementary insulin, suggests an important 2005 study in the New England Journal of Medicine (NEJM). Beneficial effects from a 6-day treatment lasted up to 18 months.

Insulin Pumps

Very young children (ages 2 - 7 years old) can successfully use insulin pumps, suggests a 2006 study in Pediatrics . The study found that insulin pumps worked better than twice-daily insulin injections.

Exercise

Regular exercise can help improve blood sugar levels in children with type 1 diabetes, and does not appear to increase the risk of low blood sugar (hypoglycemia), according to a 2006 study in the Archives of Pediatrics and Adolescent Medicine .

Type 1 Diabetes and Heart Disease

• Tight blood sugar control can cut in half the risk of heart disease in patients with diabetes, according to the latest results from the Diabetes Control and Complications Trial. Results, published in 2005 in NEJM , showed that intensive blood sugar control reduced the risk of heart attack, stroke, and other cardiovascular events by 50%.
• Improving heart disease risk factors can also help prevent diabetic neuropathy (nerve damage). A 2005 study in NEJM suggested that in addition to blood sugar control, patients should aim to reduce triglyceride levels, blood pressure, and weight.

• Review Date: 7/18/2006
• Reviewed By: Harvey Simon, M.D., Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.